FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768998510> ?p ?o ?g. }

• W2768998510 endingPage "1071" @default.
• W2768998510 startingPage "1064" @default.
• W2768998510 abstract "Head-to-head randomized studies comparing ixekizumab and secukinumab in the treatment of psoriasis are not available.To assess efficacy and quality of life using matching-adjusted indirect comparisons for treatment with ixekizumab vs. secukinumab.Psoriasis Area and Severity Index (PASI) improvement of at least 75%, 90% and 100% and Dermatology Life Quality Index (DLQI) 0/1 response rates for approved dosages of ixekizumab (160 mg at Week 0, then 80 mg every two weeks for the first 12 weeks) and secukinumab (300 mg at Weeks 0, 1, 2, 3 and 4, then 300 mg every 4 weeks) treatment were compared using data from active (etanercept and ustekinumab) and placebo-controlled studies. Comparisons were made using the Bucher (BU) method and two modified versions of the Signorovitch (SG) method (SG total and SG separate). Subsequently, results based on active treatment common comparators were combined using generic inverse-variance meta-analysis.In the meta-analysis of studies with active comparators, PASI 90 response rates were 12·7% [95% confidence interval (CI) 5·5-19·8, P = 0·0005], 10·0% (95% CI 2·1-18·0, P = 0·01) and 11·2% (95% CI 3·2-19·1, P = 0·006) higher and PASI 100 response rates were 11·7% (95% CI 5·9-17·5, P < 0·001), 12·7% (95% CI 6·0-19·4, P < 0·001) and 13·1% (95% CI 6·3-19·9, P < 0·001) higher for ixekizumab compared with secukinumab using BU, SG total and SG separate methods. PASI 75 results were comparable when SG methods were used and favoured ixekizumab when the BU method was used. Week 12 DLQI 0/1 response rates did not differ significantly.Ixekizumab had higher PASI 90 and PASI 100 responses at week 12 compared with secukinumab using adjusted indirect comparisons." @default.
• W2768998510 created "2017-12-04" @default.
• W2768998510 creator A5017726297 @default.
• W2768998510 creator A5024550161 @default.
• W2768998510 creator A5035081726 @default.
• W2768998510 creator A5038781275 @default.
• W2768998510 creator A5040921378 @default.
• W2768998510 creator A5048043719 @default.
• W2768998510 creator A5061849637 @default.
• W2768998510 creator A5069063369 @default.
• W2768998510 creator A5082315246 @default.
• W2768998510 date "2018-03-01" @default.
• W2768998510 modified "2023-10-12" @default.
• W2768998510 title "Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab" @default.
• W2768998510 cites W1541066842 @default.
• W2768998510 cites W1580608335 @default.
• W2768998510 cites W1931149717 @default.
• W2768998510 cites W1957267795 @default.
• W2768998510 cites W1973354423 @default.
• W2768998510 cites W1977443689 @default.
• W2768998510 cites W2003850078 @default.
• W2768998510 cites W2005947177 @default.
• W2768998510 cites W2008834270 @default.
• W2768998510 cites W2010780154 @default.
• W2768998510 cites W2080390872 @default.
• W2768998510 cites W2103750969 @default.
• W2768998510 cites W2118481611 @default.
• W2768998510 cites W2171889601 @default.
• W2768998510 cites W2217326824 @default.
• W2768998510 cites W2418506270 @default.
• W2768998510 cites W2541596701 @default.
• W2768998510 cites W2609891954 @default.
• W2768998510 cites W2620306249 @default.
• W2768998510 cites W2740044328 @default.
• W2768998510 cites W2767585845 @default.
• W2768998510 cites W623659374 @default.
• W2768998510 doi "https://doi.org/10.1111/bjd.16140" @default.
• W2768998510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29171861" @default.
• W2768998510 hasPublicationYear "2018" @default.
• W2768998510 type Work @default.
• W2768998510 sameAs 2768998510 @default.
• W2768998510 citedByCount "42" @default.
• W2768998510 countsByYear W27689985102018 @default.
• W2768998510 countsByYear W27689985102019 @default.
• W2768998510 countsByYear W27689985102020 @default.
• W2768998510 countsByYear W27689985102021 @default.
• W2768998510 countsByYear W27689985102022 @default.
• W2768998510 countsByYear W27689985102023 @default.
• W2768998510 crossrefType "journal-article" @default.
• W2768998510 hasAuthorship W2768998510A5017726297 @default.
• W2768998510 hasAuthorship W2768998510A5024550161 @default.
• W2768998510 hasAuthorship W2768998510A5035081726 @default.
• W2768998510 hasAuthorship W2768998510A5038781275 @default.
• W2768998510 hasAuthorship W2768998510A5040921378 @default.
• W2768998510 hasAuthorship W2768998510A5048043719 @default.
• W2768998510 hasAuthorship W2768998510A5061849637 @default.
• W2768998510 hasAuthorship W2768998510A5069063369 @default.
• W2768998510 hasAuthorship W2768998510A5082315246 @default.
• W2768998510 hasBestOaLocation W27689985101 @default.
• W2768998510 hasConcept C126322002 @default.
• W2768998510 hasConcept C142724271 @default.
• W2768998510 hasConcept C16005928 @default.
• W2768998510 hasConcept C204787440 @default.
• W2768998510 hasConcept C27081682 @default.
• W2768998510 hasConcept C2776173921 @default.
• W2768998510 hasConcept C2776260265 @default.
• W2768998510 hasConcept C2777011040 @default.
• W2768998510 hasConcept C2777575956 @default.
• W2768998510 hasConcept C2778975655 @default.
• W2768998510 hasConcept C2779745271 @default.
• W2768998510 hasConcept C2779786854 @default.
• W2768998510 hasConcept C2780132546 @default.
• W2768998510 hasConcept C2780564577 @default.
• W2768998510 hasConcept C44249647 @default.
• W2768998510 hasConcept C71924100 @default.
• W2768998510 hasConcept C90924648 @default.
• W2768998510 hasConceptScore W2768998510C126322002 @default.
• W2768998510 hasConceptScore W2768998510C142724271 @default.
• W2768998510 hasConceptScore W2768998510C16005928 @default.
• W2768998510 hasConceptScore W2768998510C204787440 @default.
• W2768998510 hasConceptScore W2768998510C27081682 @default.
• W2768998510 hasConceptScore W2768998510C2776173921 @default.
• W2768998510 hasConceptScore W2768998510C2776260265 @default.
• W2768998510 hasConceptScore W2768998510C2777011040 @default.
• W2768998510 hasConceptScore W2768998510C2777575956 @default.
• W2768998510 hasConceptScore W2768998510C2778975655 @default.
• W2768998510 hasConceptScore W2768998510C2779745271 @default.
• W2768998510 hasConceptScore W2768998510C2779786854 @default.
• W2768998510 hasConceptScore W2768998510C2780132546 @default.
• W2768998510 hasConceptScore W2768998510C2780564577 @default.
• W2768998510 hasConceptScore W2768998510C44249647 @default.
• W2768998510 hasConceptScore W2768998510C71924100 @default.
• W2768998510 hasConceptScore W2768998510C90924648 @default.
• W2768998510 hasFunder F4320307758 @default.
• W2768998510 hasIssue "5" @default.
• W2768998510 hasLocation W27689985101 @default.
• W2768998510 hasLocation W27689985102 @default.
• W2768998510 hasOpenAccess W2768998510 @default.

• next